Replies to post #2331 on SELLAS Life Sciences Group Inc (SLS)

[Hoskuld]

Aza/Ven has been shown in the CR2 population to never extend mOS past 12 months. The range is 6-12 months. That is not going to be improved upon. Aza/Ven is already the standard - why do you call venetoclax "off-label"?

The tail is GPS - there is no BATs tail of significance.